[62] demonstrated that PRMT1 downregulates the epithelial marker E‐cadherin and upregulates the mesenchymal markers N‐cadherin, Vimentin, Snail, and βcatenin in GC, thereby promoting the EMT. The gene discussed is PRMT1; the disease is gastric cancer.